Exane Derivatives’s CrowdStrike CRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.35K Sell
32
-4,852
-99% -$220K ﹤0.01% 474
2022
Q1
$277K Buy
+4,884
New +$228K 0.08% 264
2021
Q4
Sell
-1,388
Closed -$85.3K 899
2021
Q3
$85.3K Buy
1,388
+860
+163% +$55.5K 0.02% 544
2021
Q2
$34.5K Buy
+528
New +$28.4K 0.01% 672
2021
Q1
Sell
-56
Closed -$2.96K 937
2020
Q4
$2.96K Buy
+56
New +$2.18K ﹤0.01% 593

Other funds holding CRWD

Exane Derivatives's CRWD Position: Q2 2022 in Review

Exane Derivatives reduced its CrowdStrike (CRWD) stake by 99% in Q2 2022, selling an estimated $220K and leaving 32 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #474.

Exane Derivatives first reported a position in CRWD in Q4 2020 and has held it in 5 quarters since. The position peaked at $277K in Q1 2022. 1,036 funds tracked by Wall St. Rank hold CRWD as of Q2 2022.

  • Exane Derivatives held 32 shares of CrowdStrike worth $1.35K as of Q2 2022.
  • Exane Derivatives sold 4,852 CrowdStrike shares in Q2 2022, an estimated $220K.
  • CrowdStrike made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #474 holding.
  • Exane Derivatives first reported a position in CrowdStrike in Q4 2020 and has held it in 5 quarters since.
  • Exane Derivatives's CrowdStrike position peaked at $277K in Q1 2022.
  • 1,036 funds tracked by Wall St. Rank held CrowdStrike as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.